Healthcare provider profile · identity verified

Nicole M. Strohl, DO

Family Practice · WYOMISSING, PA · NPI 1437460888

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	530	156
Omeprazole	Omeprazole	372	99
Levothyroxine Sodium	Levothyroxine Sodium	361	92
Amlodipine Besylate	Amlodipine Besylate	334	102
Lisinopril	Lisinopril	274	77
Metformin Hcl	Metformin Hcl	200	51
Metoprolol Succinate	Metoprolol Succinate	186	53
Gabapentin	Gabapentin	181	52
Losartan Potassium	Losartan Potassium	179	49
Trazodone Hcl	Trazodone Hcl	166	45
Olmesartan Medoxomil	Olmesartan Medoxomil	162	46
Simvastatin	Simvastatin	131	34
Sertraline Hcl	Sertraline Hcl	130	39
Rosuvastatin Calcium	Rosuvastatin Calcium	125	39
Pantoprazole Sodium	Pantoprazole Sodium	122	34
Bisoprolol Fumarate	Bisoprolol Fumarate	109	33
Metoprolol Tartrate	Metoprolol Tartrate	107	28
Hydrochlorothiazide	Hydrochlorothiazide	84	27
Venlafaxine Hcl Er	Venlafaxine Hcl	82	19
Meloxicam	Meloxicam	79	23
Fluticasone Propionate	Fluticasone Propionate	75	18
Prednisone	Prednisone	75	65
Pravastatin Sodium	Pravastatin Sodium	73	20
Montelukast Sodium	Montelukast Sodium	71	20
Escitalopram Oxalate	Escitalopram Oxalate	68	18
Ezetimibe	Ezetimibe	67	14
Alprazolam	Alprazolam	65	19
Bupropion Xl	Bupropion Hcl	65	17
Topiramate	Topiramate	61	22
Clopidogrel	Clopidogrel Bisulfate	59	17
Azithromycin	Azithromycin	58	51
Albuterol Sulfate Hfa	Albuterol Sulfate	55	25
Alendronate Sodium	Alendronate Sodium	55	15
Furosemide	Furosemide	55	25
Trulicity	Dulaglutide	55	14
Allopurinol	Allopurinol	54	11
Duloxetine Hcl	Duloxetine Hcl	54	14
Tamsulosin Hcl	Tamsulosin Hcl	54	15
Synthroid	Levothyroxine Sodium	53	16
Glipizide	Glipizide	48	17
Metformin Hcl Er	Metformin Hcl	48	12
Sumatriptan Succinate	Sumatriptan Succinate	48	suppressed
Eliquis	Apixaban	47	11
Ramipril	Ramipril	41	11
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Celecoxib	Celecoxib	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	12
Potassium Chloride	Potassium Chloride	36	12
Doxycycline Hyclate	Doxycycline Hyclate	35	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Mirtazapine	Mirtazapine	34	12
Ozempic	Semaglutide	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Fluconazole	Fluconazole	28	14
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Nitroglycerin	Nitroglycerin	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Ondansetron Odt	Ondansetron	25	16
Finasteride	Finasteride	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Atenolol	Atenolol	23	suppressed
Nystatin	Nystatin	23	11
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Spironolactone	Spironolactone	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Calcitriol	Calcitriol	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Valsartan	Valsartan	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	11
Warfarin Sodium	Warfarin Sodium	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Lorazepam	Lorazepam	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Enalapril Maleate	Enalapril Maleate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Lactulose	Lactulose	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error